FDA approves prescription leucovorin for autism treatment; HHS addresses investment and regulatory concerns involving CMS administrator Dr. Mehmet Oz amid public discourse.

Recent U.S. health policy debates focus on autism's classification, NIH's new autism registry, data privacy concerns, and implications for insurance and early intervention programs.

Insights on recent shifts in U.S. health policy: autism research, drug pricing reforms, HHS operational cuts, abortion access, and legal challenges to insurance preventive care coverage.